Oz Adler - 31 Mar 2026 Form 4 Insider Report for Polyrizon Ltd. (PLRZ)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Apr 2026, 16:15:11 UTC
Prior SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Oz Adler

Key filing fact

Oz Adler filed Form 4 for Polyrizon Ltd. (PLRZ) on 01 Apr 2026.

Key facts

  • This page summarizes Oz Adler's Form 4 filing for Polyrizon Ltd. (PLRZ).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Apr 2026, 16:15.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: -$39,669.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001973096 Primary reporting owner

Adler Oz

Relationship
Director
Address
C/O POLYRIZON LTD., 9 HAPNINA STREET, RAANANA, ISRAEL
Signature
/s/ Oz Adler
Signature date
01 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PLRZ transaction

Ordinary Shares

Sale

Transaction value
$39,669
Shares
-3,292
Change %
-14%
Price
$12.05
Shares after
19,850
Date
31 Mar 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.1041, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F2

Consists of (1) 3,363 ordinary shares, (2) 29 restricted ordinary shares that vest in equal installments on a monthly basis, subject to the Reporting Person's continued service, and (3) 16,458 restricted ordinary shares that vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .